Susanna Naggie, MD

Publications

Rallon, NI, Naggie, S, Restrepo, C, McHutchison, J, Soriano, V, and Benito, JM. "IL28B genotypes strongly influence early viral kinetics in HIV/HCV-coinfected patients treated with peginterferon-alpha/ribavirin - implications using directly acting antivirals." International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies. Los Cabos, MEXICO. June 7, 2011 - June 11, 2011.: INT MEDICAL PRESS LTD, January 1, 2011.

Scholars@Duke

Rallón, NI, Soriano, V, Naggie, S, Restrepo, C, Goldstein, D, Vispo, E, McHutchison, J, and Benito, JM. "IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin." AIDS 25, no. 8 (2011): 1025-1033.

Full Text

Thompson, AJ, Muir, AJ, Sulkowski, MS, Patel, K, Tillmann, HL, Clark, PJ, Naggie, S, Fellay, J, Ge, D, McCarthy, JJ, Goldstein, DB, and McHutchison, JG. "Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype." Hepatology (Baltimore, Md.) 52, no. 6 (December 2010): 2243-2244. (Letter)

PMID
20890887
Full Text

Thompson, AJ, Santoro, R, Piazzolla, V, Clark, PJ, Naggie, S, Tillmann, HL, Patel, K, Muir, AJ, Shianna, KV, Mottola, L, Petruzzellis, D, Romano, M, Sogari, F, Facciorusso, D, Goldstein, DB, McHutchison, JG, and Mangia, A. "Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR." Hepatology (November 12, 2010).

PMID
21225645
Full Text

Medrano, J, Neukam, K, Rallón, N, Rivero, A, Resino, S, Naggie, S, Caruz, A, Calvino, A, Macías, J, Benito, JM, Sánchez-Piedra, C, Vispo, E, Barreiro, P, McHutchison, J, Pineda, JA, and Soriano, V. "Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 51, no. 10 (November 2010): 1209-1216.

PMID
20964522
Full Text

Thompson, AJ, Santoro, R, Piazzolla, V, Tillman, HL, Patel, K, Clark, PJ, Naggie, S, Shianna, K, Mottola, L, Petruzzellis, D, Romano, M, Sogari, F, Facciorusso, D, Goldstein, DB, McHutchison, JG, and Mangia, A. "ITPA GENETIC VARIANTS ARE PROTECTIVE AGAINST ANEMIA DURING ANTIVIRAL THERAPY FOR G2/3 HCV, BUT DO NOT DECREASE THE NEED FOR RBV DOSE REDUCTION OR INCREASE SVR." October 2010.

Scholars@Duke

Naggie, S, Rallon, NI, Benito, JM, Morello, J, Rodriguez-Novoa, S, Clark, PJ, Thompson, AJ, Shianna, K, Vispo, E, McHutchison, JG, Goldstein, DB, and Soriano, V. "VARIANTS IN THE ITPA GENE PROTECT AGAINST EARLY RIBAVIRIN-INDUCED HEMOLYTIC ANEMIA IN HIV/HCV CO-INFECTED PATIENTS." October 2010.

Scholars@Duke

Rallon, NI, Naggie, S, Restrepo, C, Goldstein, DB, McHutchison, JG, Soriano, V, and Benito, JM. "THE IL28B CC GENOTYPE STRONGLY PREDICTS EARLY VIRAL KINETICS IN HIV-INFECTED PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGINTERFERON-RIBAVIRIN." October 2010.

Scholars@Duke

Thompson, AJ, Singh, A, Fellay, J, Ge, D, Sulkowski, MS, Muir, AJ, Tillmann, HL, Patel, K, Naggie, S, Shianna, K, Afdhal, NH, Jacobson, IM, Esteban, R, Poordad, F, Lawitz, E, McCone, J, Shiffman, ML, Galler, GW, King, JW, Kwo, PY, Nyberg, LM, Noviello, S, Boparai, N, Koury, KJ, Pedicone, L, Brass, CA, Albrecht, JK, Goldstein, DB, and McHutchison, JG. "GENOME-WIDE ASSOCIATION STUDY IDENTIFIES AN ASSOCIATION BETWEEN ITPA GENE VARIANTS AND IFN-INDUCED THROMBOCYTOPENIA IN CHRONIC HEPATITIS C PATIENTS FROM THE IDEAL STUDY." October 2010.

Scholars@Duke

Thompson, AJ, Muir, AJ, Sulkowski, MS, Patel, K, Tillmann, HL, Clark, PJ, Naggie, S, Fellay, J, Ge, D, McCarthy, J, Goldstein, DB, and McHutchison, JG. "HEPATITIS C TRIALS THAT COMBINE INVESTIGATIONAL AGENTS WITH PEGYLATED-INTERFERON-alpha SHOULD BE STRATIFIED BY IL28B GENOTYPE." October 2010.

Scholars@Duke

Pages